Is Kingstone Cos., Inc. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than the peer average of 17.88 for Crawford & Co., and its EV to Sales ratio of 1.25, which suggests potential for growth relative to its sales. Additionally, Kingstone's ROE of 25.77% highlights its strong profitability compared to peers.
In terms of peer comparison, Kingstone's P/E ratio of 11 is notably lower than Crawford & Co.'s 17.88, while its EV to EBITDA of 76.30 is much higher than GoHealth, Inc.'s 0.4180, indicating a disparity in valuation metrics across the sector. Recent stock performance shows that Kingstone outperformed the S&P 500 over the past year with a return of 34.66% compared to the index's 12.65%, reinforcing the notion that the stock may be undervalued relative to its strong performance and growth potential.